Randy Milby - Jan 14, 2022 Form 4 Insider Report for Hillstream BioPharma Inc. (THAR)

Role
Chief Executive Officer, Director
Signature
/s/ Randy Milby
Stock symbol
THAR
Transactions as of
Jan 14, 2022
Transactions value $
$83,714
Form type
4
Date filed
1/20/2022, 08:23 AM
Previous filing
Jan 20, 2022
Next filing
Apr 19, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction THAR Common Stock Conversion of derivative security $87.9K +27.5K +1.55% $3.20* 1.8M Jan 14, 2022 Direct
transaction THAR Common Stock Conversion of derivative security $98.5K +30.8K +1.71% $3.20* 1.83M Jan 14, 2022 Direct
transaction THAR Common Stock Conversion of derivative security $2.17K +678 +0.04% $3.20* 1.83M Jan 14, 2022 Direct
transaction THAR Common Stock Conversion of derivative security $32.6K +10.2K +0.56% $3.20* 1.84M Jan 14, 2022 Direct
transaction THAR Common Stock Conversion of derivative security $59.6K +18.6K +1.01% $3.20* 1.86M Jan 14, 2022 Direct
transaction THAR Common Stock Conversion of derivative security $59.6K +18.6K +1% $3.20* 1.88M Jan 14, 2022 Direct
transaction THAR Common Stock Conversion of derivative security $43.2K +13.5K +0.72% $3.20* 1.89M Jan 14, 2022 Direct
transaction THAR Common Stock Conversion of derivative security $43.1K +13.5K +0.71% $3.20* 1.91M Jan 14, 2022 Direct
transaction THAR Common Stock Conversion of derivative security $43K +13.4K +0.71% $3.20* 1.92M Jan 14, 2022 Direct
transaction THAR Common Stock Conversion of derivative security $53.6K +16.8K +0.87% $3.20* 1.94M Jan 14, 2022 Direct
transaction THAR Common Stock Conversion of derivative security $32.1K +10K +0.52% $3.20* 1.95M Jan 14, 2022 Direct
transaction THAR Common Stock Conversion of derivative security $37.3K +11.7K +0.6% $3.20* 1.96M Jan 14, 2022 Direct
transaction THAR Common Stock Conversion of derivative security $584K +182K +9.32% $3.20* 2.14M Jan 14, 2022 Direct
transaction THAR Common Stock Conversion of derivative security $53.2K +16.6K +0.78% $3.20* 2.16M Jan 14, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction THAR Convertible Note Conversion of derivative security -$80K 0 Jan 14, 2022 Common stock 27.5K $3.20 Direct F1
transaction THAR Convertible Note Conversion of derivative security -$90K 0 Jan 14, 2022 Common stock 30.8K $3.20 Direct F2
transaction THAR Convertible Note Conversion of derivative security -$2K 0 Jan 14, 2022 Common stock 678 $3.20 Direct F3
transaction THAR Convertible Note Conversion of derivative security -$30K 0 Jan 14, 2022 Common stock 10.2K $3.20 Direct F4
transaction THAR Convertible Note Conversion of derivative security -$55K 0 Jan 14, 2022 Common stock 18.6K $3.20 Direct F5
transaction THAR Convertible Note Conversion of derivative security -$55.1K 0 Jan 14, 2022 Common stock 18.6K $3.20 Direct F6
transaction THAR Convertible Note Conversion of derivative security -$40K 0 Jan 14, 2022 Common stock 13.5K $3.20 Direct F7
transaction THAR Convertible Note Conversion of derivative security -$40K 0 Jan 14, 2022 Common stock 13.5K $3.20 Direct F8
transaction THAR Convertible Note Conversion of derivative security -$40K 0 Jan 14, 2022 Common stock 13.4K $3.20 Direct F9
transaction THAR Convertible Note Conversion of derivative security -$50K 0 Jan 14, 2022 Common stock 16.8K $3.20 Direct F10
transaction THAR Convertible Note Conversion of derivative security -$30K 0 Jan 14, 2022 Common stock 10K $3.20 Direct F11
transaction THAR Convertible Note Conversion of derivative security -$35K 0 Jan 14, 2022 Common stock 11.7K $3.20 Direct F12
transaction THAR Convertible Note Conversion of derivative security -$549K 0 Jan 14, 2022 Common stock 182K $3.20 Direct F13
transaction THAR Convertible Note Conversion of derivative security -$50K 0 Jan 14, 2022 Common stock 16.6K $3.20 Direct F14
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On January 21, 2020, the Registrant issued the Reporting Person an $80,000 note which matures on the earlier of (i) January 20, 2022 and (ii) the closing of the Next Equity Financing (as defined therein). The principal amount of the note together with accrued interest thereon automatically converts into the type of Equity Securities (as defined therein) issued in the Next Equity Financing. Pursuant to the terms of the note, because the Registrant's initial public offering qualified as a Next Equity Financing, the note automatically converted into shares of the Registrant's common stock.
F2 On February 27, 2020, the Registrant issued the Reporting Person a $90,000 note which matures on the earlier of (i) February 26, 2022 and (ii) the closing of the Next Equity Financing (as defined therein). The principal amount of the note together with accrued interest thereon automatically converts into the type of Equity Securities (as defined therein) issued in the Next Equity Financing. Pursuant to the terms of the note, because the Registrant's initial public offering qualified as a Next Equity Financing, the note automatically converted into shares of the Registrant's common stock.
F3 On April 23, 2020, the Registrant issued the Reporting Person a $2,000 note which matures on the earlier of (i) April 23, 2022 and (ii) the closing of the Next Equity Financing (as defined therein). The principal amount of the note together with accrued interest thereon automatically converts into the type of Equity Securities (as defined therein) issued in the Next Equity Financing. Pursuant to the terms of the note, because the Registrant's initial public offering qualified as a Next Equity Financing, the note automatically converted into shares of the Registrant's common stock.
F4 On April 24, 2020, the Registrant issued the Reporting Person a $30,000 note which matures on the earlier of (i) April 24, 2022 and (ii) the closing of the Next Equity Financing (as defined therein). The principal amount of the note together with accrued interest thereon automatically converts into the type of Equity Securities (as defined therein) issued in the Next Equity Financing. Pursuant to the terms of the note, because the Registrant's initial public offering qualified as a Next Equity Financing, the note automatically converted into shares of the Registrant's common stock.
F5 On May 8, 2020, the Registrant issued the Reporting Person a $55,000 note which matures on the earlier of (i) May 8, 2022 and (ii) the closing of the Next Equity Financing (as defined therein). The principal amount of the note together with accrued interest thereon automatically converts into the type of Equity Securities (as defined therein) issued in the Next Equity Financing. Pursuant to the terms of the note, because the Registrant's initial public offering qualified as a Next Equity Financing, the note automatically converted into shares of the Registrant's common stock.
F6 On May 19, 2020, the Registrant issued the Reporting Person a $55,068 note which matures on the earlier of (i) May 19, 2022 and (ii) the closing of the Next Equity Financing (as defined therein). The principal amount of the note together with accrued interest thereon automatically converts into the type of Equity Securities (as defined therein) issued in the Next Equity Financing. Pursuant to the terms of the note, because the Registrant's initial public offering qualified as a Next Equity Financing, the note automatically converted into shares of the Registrant's common stock.
F7 On June 3, 2020, the Registrant issued the Reporting Person a $40,000 note which matures on the earlier of (i) June 3, 2022 and (ii) the closing of the Next Equity Financing (as defined therein). The principal amount of the note together with accrued interest thereon automatically converts into the type of Equity Securities (as defined therein) issued in the Next Equity Financing. Pursuant to the terms of the note, because the Registrant's initial public offering qualified as a Next Equity Financing, the note automatically converted into shares of the Registrant's common stock.
F8 On June 25, 2020, the Registrant issued the Reporting Person a $40,000 note which matures on the earlier of (i) June 25, 2022 and (ii) the closing of the Next Equity Financing (as defined therein). The principal amount of the note together with accrued interest thereon automatically converts into the type of Equity Securities (as defined therein) issued in the Next Equity Financing. Pursuant to the terms of the note, because the Registrant's initial public offering qualified as a Next Equity Financing, the note automatically converted into shares of the Registrant's common stock.
F9 On July 13, 2020, the Registrant issued the Reporting Person a $40,000 note which matures on the earlier of (i) July 13, 2022 and (ii) the closing of the Next Equity Financing (as defined therein). The principal amount of the note together with accrued interest thereon automatically converts into the type of Equity Securities (as defined therein) issued in the Next Equity Financing. Pursuant to the terms of the note, because the Registrant's initial public offering qualified as a Next Equity Financing, the note automatically converted into shares of the Registrant's common stock.
F10 On August 3, 2020, the Registrant issued the Reporting Person a $50,000 note which matures on the earlier of (i) August 3, 2022 and (ii) the closing of the Next Equity Financing (as defined therein). The principal amount of the note together with accrued interest thereon automatically converts into the type of Equity Securities (as defined therein) issued in the Next Equity Financing. Pursuant to the terms of the note, because the Registrant's initial public offering qualified as a Next Equity Financing, the note automatically converted into shares of the Registrant's common stock.
F11 On August 31, 2020, the Registrant issued the Reporting Person a $30,000 note which matures on the earlier of (i) August 31, 2022 and (ii) the closing of the Next Equity Financing (as defined therein). The principal amount of the note together with accrued interest thereon automatically converts into the type of Equity Securities (as defined therein) issued in the Next Equity Financing. Pursuant to the terms of the note, because the Registrant's initial public offering qualified as a Next Equity Financing, the note automatically converted into shares of the Registrant's common stock.
F12 On September 21, 2020, the Registrant issued the Reporting Person a $35,000 note which matures on the earlier of (i) September 21, 2022 and (ii) the closing of the Next Equity Financing (as defined therein). The principal amount of the note together with accrued interest thereon automatically converts into the type of Equity Securities (as defined therein) issued in the Next Equity Financing. Pursuant to the terms of the note, because the Registrant's initial public offering qualified as a Next Equity Financing, the note automatically converted into shares of the Registrant's common stock.
F13 On September 27, 2020, the Registrant issued the Reporting Person notes in the aggregate principal amount of $549,058.09. The notes mature on the earlier of (i) September 27, 2022 and (ii) the closing of the Next Equity Financing (as defined therein). The principal amount of the notes together with accrued interest thereon automatically converts into the type of Equity Securities (as defined therein) issued in the Next Equity Financing. Pursuant to the terms of the note, because the Registrant's initial public offering qualified as a Next Equity Financing, the note automatically converted into shares of the Registrant's common stock.
F14 On September 28, 2020, the Registrant issued the Reporting Person a $50,000 note which matures on the earlier of (i) September 28, 2022 and (ii) the closing of the Next Equity Financing (as defined therein). The principal amount of the note together with accrued interest thereon automatically converts into the type of Equity Securities (as defined therein) issued in the Next Equity Financing. Pursuant to the terms of the note, because the Registrant's initial public offering qualified as a Next Equity Financing, the note automatically converted into shares of the Registrant's common stock.

Remarks:

This is the first of the Form 4s.